Investigation of Respiratory Muscle Sarcopenia in Patients With Systemic Sclerosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorSelcuk University
About this trial
The aim of this study was to investigate respiratory muscle sarcopenia in individuals with systemic sclerosis. The main question it aims to answer is:
What is the prevalence of respiratory muscle sarcopenia in patients with systemic sclerosis? Participants body composition (bioelectrical impedance), hand grip strength (hand dynanometer), physical performance tests (5 repetition sit-and-stand test, 4-meter walk test, Timed up-and-go test) and respiratory muscle strength were evaluated.
Eligibility criteria
Qualifiers
Being between the ages of 18-75
2013 To be diagnosed with systemic sclerosis according to ACR/EULAR classification criteria
Being clinically stable
Ability to adapt to tests (visual, cognitive, cooperative)
Disqualifiers
Those with neurological and/or musculoskeletal problems that may affect the work
Presence of severe joint contracture or painful ulcers that may affect muscle strength measurement and walking
Presence of severe infection or sepsis
Being diagnosed with a known additional rheumatologic disease
Trial design
Treatments tested in this trial
- Not listed
Trial groups
85 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov